Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05562349 · ClinicalTrials.gov registry record · Phase 2

Clavulanic Acid for the Treatment of Cocaine Use Disorder

A Phase 2 study of Cocaine Dependence, sponsored by Temple University.

Active
Registry status
Phase 2
Development phase
65
Enrollment target
2
Study locations

NCT05562349 is a Phase 2 study of Cocaine Dependence that is active but no longer recruiting, run by Temple University. The registered enrollment target is 65 participants, below the 297-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05562349, a Phase 2 study of Cocaine Dependence, is active but no longer recruiting, sponsored by Temple University.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
65 participants
Enrollment target
2
Study locations

Study Summary

A dose escalation study to assess the efficacy and safety of Clavulanic Acid (CLAV) vs. placebo (PBO) for the treatment of cocaine use disorder (CUD)

Conditions Studied

Cocaine Dependence

Interventions

  • DRUG Placebo
  • DRUG Clavulanic Acid Only Product

Study Locations (2)

Pennsylvania

  • University of Pennsylvania - Philadelphia

South Carolina

  • MUSC - Charleston

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2023-05-03
Est. Completion 2024-07
Phase Phase 2

Sponsor

Temple University

163 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05562349

The ClinicalTrials.gov registry entry for NCT05562349 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 297-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (78% lower). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cocaine Dependence appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05562349 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, South Carolina.

Frequently Asked Questions

What is clinical trial NCT05562349 about?

NCT05562349 is a clinical study titled "Clavulanic Acid for the Treatment of Cocaine Use Disorder". A dose escalation study to assess the efficacy and safety of Clavulanic Acid (CLAV) vs. placebo (PBO) for the treatment of cocaine use disorder (CUD)

What is the current status of trial NCT05562349?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 65 participants. The study started on 2023-05-03. Estimated completion is 2024-07.

What conditions does trial NCT05562349 study?

This clinical trial studies the following conditions: Cocaine Dependence.

What interventions are being tested in trial NCT05562349?

The interventions under investigation include: Placebo (DRUG), Clavulanic Acid Only Product (DRUG).

Who is sponsoring clinical trial NCT05562349?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05562349 being conducted?

This trial has 2 study locations across Pennsylvania, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cocaine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cocaine Dependence

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.